Peter Lim Eng Hock

Rowsley renames to Thomson Medical Group as shareholders approve healthcare acquisitions

SINGAPORE (Mar 24): The shareholders of Rowsley have voted in favour of the proposed healthcare acquisition from controlling shareholder Peter Lim Eng Hock.

The proposed acquisition includes a 100% stake in Thomson Medical and a 70.35% stake in Bursa-listed TMC Life Sciences (TMCLS) which owns Tropicana Medical Centre.

Rowsley says sale price of TMC Life Sciences warrants set at $34.8 mil

SINGAPORE (Mar 19): Rowsley says the cash consideration for the warrants of TMC Life Sciences (TMCLS) is set at RM103.75 million ($34.8 million).

This is derived from the volume weighted average price of TMCLS warrants traded on Bursa Securities for the one-month period to March 19 of MYR 0.1737 per warrant, multiplied by an aggregate of some 597.3 million TMCLS warrants.

As announced last Dec, Rowsley is acquiring the healthcare businesses of Thomson Medical from controlling shareholder Peter Lim for $1.6 billion.

Rowsley shares jump 23% on announcement of healthcare assets acquisition

SINGAPORE (Dec 18): Shares of Rowsley jumped 22.5%, or 2.5 cents, to close at 13.6 cents on Monday after the real estate and investment firm announced it is acquiring $1.6 billion worth of healthcare assets from controlling shareholder Peter Lim Eng Hock.

Rowsley on Monday entered into a sale and purchase agreement to acquire 100% of Sasteria from billionaire former stockbroker Lim.

Sasteria is the owner of Thomson Medical and the controlling shareholder of Malaysia-based TMC Life Sciences (TMCLS) with a 70.36% stake.

Rowsley signs binding agreement to acquire $1.6 bil worth of healthcare assets from Peter Lim; to be renamed Thomson Medical Group

SINGAPORE (Dec 18): Rowsley today signed a binding agreement to acquire a 100% of Sasteria from controlling shareholder Lim Eng Hock, better known as Peter Lim, for $1.6 billion.

Sasteria is the owner of Thomson Medical and the controlling shareholder of Malaysia-based TMC Life Sciences (TMCLS) with a 70.36% stake.

Following the acquisition, Rowsley will be changing its name to Thomson Medical Group, pending approval from shareholders.

Rowsley reports 3Q net loss of $9.8 mil on fair value loss

SINGAPORE (Nov 3): Rowsley, the company controlled by Peter Lim Eng Hock, recorded a 3Q net loss of $9.8 million which included a $7.9 million fair value loss.

The fair value change arose from the remeasurement of the company’s purchase consideration payable in the earn-out shares related to the acquisitions it had made.

Rowsley to acquire $1.9 bil in healthcare assets from controlling shareholder Peter Lim

SINGAPORE (July 18): Rowsley, the real estate and investment firm, is expanding into the healthcare sector in an acquisition of healthcare assets worth $1.9 billion from its controlling shareholder.

Singapore billionaire Peter Lim will inject 100% of Thomson Medical and 70.36% of TMC Life Sciences Berhad, a Bursa Malaysia listed company, into Rowsley.

The proposed acquisition will be financed through the issuance of new shares to Lim at 7.5 cents each, 0.2 cent higher than its last traded price of 7.3 cents before the trading halt for the announcement.

Be informed of the stories that matter

Subscribe

Be informed of the stories that matter